NuVasive (NUVA) ROE - Return on Equity
Current and historical Return on Equity (ROE) values for NuVasive (NUVA) over the last 10 years.
|Medical||Medical Products Manufacturing||$3.350B||$0.962B|
|NUVASIVE is a medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders. The Company's product portfolio is focused on applications in the over $4.2 billion U.S. spine fusion market. The Company's current principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery, or MAS, as well as a growing offering of cervical and motion preservation products.|